Publicaciones en colaboración con investigadores/as de Universidad de Salamanca (20)

2023

  1. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

2022

  1. Evolutionary Origins of Metabolic Reprogramming in Cancer

    International journal of molecular sciences, Vol. 23, Núm. 20

  2. Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer

    Cancers, Vol. 14, Núm. 2

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. The pseudokinase TRIB3 negatively regulates the HER2 receptor pathway and is a biomarker of good prognosis in luminal breast cancer

    Cancers, Vol. 13, Núm. 21

2020

  1. Glucose metabolism links astroglial mitochondria to cannabinoid effects

    Nature, Vol. 583, Núm. 7817, pp. 603-608

  2. Stromal SNAI2 is required for ERBB2 breast cancer progression

    Cancer Research, Vol. 80, Núm. 23, pp. 5216-5230

2018

  1. Supplementary data for the biological age linked to oxidative stress modifies breast cancer aggressiveness

    Data in Brief

  2. The biological age linked to oxidative stress modifies breast cancer aggressiveness

    Free Radical Biology and Medicine, Vol. 120, pp. 133-146

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  3. Missing heritability of complex diseases: Enlightenment by genetic variants from intermediate phenotypes

    BioEssays, Vol. 38, Núm. 7, pp. 664-673

2015

  1. A new role of SNAI2 in postlactational involution of the mammary gland links it to luminal breast cancer development

    Oncogene, Vol. 34, Núm. 36, pp. 4777-4790

  2. Unraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approach

    Genome Biology, Vol. 16, Núm. 1

2014

  1. Impaired wound repair in adult endoglin heterozygous mice associated with lower NO bioavailability

    Journal of Investigative Dermatology, Vol. 134, Núm. 1, pp. 247-255

2012

  1. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

2010

  1. The role of the TGF-β coreceptor endoglin in cancer

    TheScientificWorldJournal, Vol. 10, pp. 2367-2384

2008

  1. S-endoglin expression is induced in senescent endothelial cells and contributes to vascular pathology

    Circulation Research, Vol. 103, Núm. 12, pp. 1383-1392

2005

  1. Characterization of murine S-endoglin isoform and its effects on tumor development

    Oncogene, Vol. 24, Núm. 27, pp. 4450-4461

2003

  1. Expression of the TGF-β coreceptor endoglin in epidermal keratinocytes and its dual role in multistage mouse skin carcinogenesis

    Oncogene, Vol. 22, Núm. 38, pp. 5976-5985